530 related articles for article (PubMed ID: 27439403)
1. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
[TBL] [Abstract][Full Text] [Related]
2. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin in children admitted to hospital with community acquired pneumonia.
Moulin F; Raymond J; Lorrot M; Marc E; Coste J; Iniguez JL; Kalifa G; Bohuon C; Gendrel D
Arch Dis Child; 2001 Apr; 84(4):332-6. PubMed ID: 11259234
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of bacterial and viral community-acquired pneumonia in children.
Don M; Valent F; Korppi M; Canciani M
Pediatr Int; 2009 Feb; 51(1):91-6. PubMed ID: 19371285
[TBL] [Abstract][Full Text] [Related]
5. A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR.
Alcoba G; Keitel K; Maspoli V; Lacroix L; Manzano S; Gehri M; Tabin R; Gervaix A; Galetto-Lacour A
Eur J Pediatr; 2017 Jun; 176(6):815-824. PubMed ID: 28474099
[TBL] [Abstract][Full Text] [Related]
6. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.
Toikka P; Irjala K; Juvén T; Virkki R; Mertsola J; Leinonen M; Ruuskanen O
Pediatr Infect Dis J; 2000 Jul; 19(7):598-602. PubMed ID: 10917215
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and inflammatory markers in pediatric pneumonia: a prospective study.
Berg AS; Inchley CS; Fjaerli HO; Leegaard TM; Lindbaek M; Nakstad B
Eur J Pediatr; 2017 May; 176(5):629-638. PubMed ID: 28281094
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory response in mixed viral-bacterial community-acquired pneumonia.
Bello S; Mincholé E; Fandos S; Lasierra AB; Ruiz MA; Simon AL; Panadero C; Lapresta C; Menendez R; Torres A
BMC Pulm Med; 2014 Jul; 14():123. PubMed ID: 25073709
[TBL] [Abstract][Full Text] [Related]
9. Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children.
Bhuiyan MU; Blyth CC; West R; Lang J; Rahman T; Granland C; de Gier C; Borland ML; Thornton RB; Kirkham LS; Martin A; Richmond PC; Smith DW; Jaffe A; Snelling TL
BMC Pulm Med; 2019 Apr; 19(1):71. PubMed ID: 30940126
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired Pneumonia.
Esposito S; Di Gangi M; Cardinale F; Baraldi E; Corsini I; Da Dalt L; Tovo PA; Correra A; Villani A; Sacco O; Tenero L; Dones P; Gambino M; Zampiero A; Principi N;
PLoS One; 2016; 11(11):e0163262. PubMed ID: 27846213
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in Pediatric Community-Acquired Pneumonia.
Principi N; Esposito S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218726
[TBL] [Abstract][Full Text] [Related]
13. The incidence and etiology of community-acquired pneumonia in fever outpatients.
Bao Z; Yuan X; Wang L; Sun Y; Dong X
Exp Biol Med (Maywood); 2012 Nov; 237(11):1256-61. PubMed ID: 23239436
[TBL] [Abstract][Full Text] [Related]
14. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination?
Korppi M
Pediatr Int; 2004 Oct; 46(5):545-50. PubMed ID: 15491381
[TBL] [Abstract][Full Text] [Related]
15. The discriminative value of C-reactive protein levels in distinguishing between community-acquired bacteraemic and respiratory virus-associated lower respiratory tract infections in HIV-1-infected and -uninfected children.
Lala SG; Madhi SA; Pettifor JM
Ann Trop Paediatr; 2002 Sep; 22(3):271-9. PubMed ID: 12369494
[TBL] [Abstract][Full Text] [Related]
16. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
Galetto-Lacour A; Alcoba G; Posfay-Barbe KM; Cevey-Macherel M; Gehri M; Ochs MM; Brookes RH; Siegrist CA; Gervaix A
Pediatr Infect Dis J; 2013 Nov; 32(11):1175-9. PubMed ID: 23694836
[TBL] [Abstract][Full Text] [Related]
17. Bacterial and viral etiology in hospitalized community acquired pneumonia with molecular methods and clinical evaluation.
Çağlayan Serin D; Pullukçu H; Ciçek C; Sipahi OR; Taşbakan S; Atalay S;
J Infect Dev Ctries; 2014 Apr; 8(4):510-8. PubMed ID: 24727518
[TBL] [Abstract][Full Text] [Related]
18. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
[TBL] [Abstract][Full Text] [Related]
19. Differences in inflammatory marker patterns for adult community-acquired pneumonia patients induced by different pathogens.
Liu M; Li H; Xue CX; Gu L; Qu JX; Yu XM; Wang YM; Liu YM; Cao B
Clin Respir J; 2018 Mar; 12(3):974-985. PubMed ID: 28139879
[TBL] [Abstract][Full Text] [Related]
20. Validity of the quick-read C-reactive protein test in the prediction of bacterial pneumonia in the pediatric emergency department.
Marcus N; Mor M; Amir L; Mimouni M; Waisman Y
Eur J Emerg Med; 2008 Jun; 15(3):158-61. PubMed ID: 18460957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
